Blue-Owl-Capital-Holdings-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
74
Total Value
310078266
Accession Number
0000950123-25-005588
Form Type
13F-HR
Manager Name
Blue-Owl-Capital-Holdings-Lp
Data Enrichment
57% identified
42 identified32 unidentified

Holdings

74 positions
Manager:
Search and click to pin securities to the top
Page 2 of 4
PLIANT THERAPEUTICS, INC.
Shares:3.0M
Value:$4.0M
PALVELLA THERAPEUTICS, INC.
Shares:140.3K
Value:$3.9M
Repare Therapeutics Inc.
Shares:3.4M
Value:$3.4M
E2open Parent Holdings, Inc.
Shares:1.7M
Value:$3.3M
Mineralys Therapeutics, Inc.
Shares:206.3K
Value:$3.3M
COMPASS Pathways plc
Shares:1.1M
Value:$3.2M
Tango Therapeutics, Inc.
Shares:2.1M
Value:$2.9M
Keros Therapeutics, Inc.
Shares:266.0K
Value:$2.7M
Aquestive Therapeutics, Inc.
Shares:920.0K
Value:$2.7M
NEXTNAV INC.
Shares:198.8K
Value:$2.4M
56608A105
Shares:91.4K
Value:$1.4M
Verona Pharma plc
Shares:18.3K
Value:$1.2M
ENTERPRISE PRODUCTS PARTNERS L.P.
Shares:31.3K
Value:$1.1M
ADC Therapeutics SA
Shares:733.6K
Value:$1.0M
Inozyme Pharma, Inc.
Shares:1.1M
Value:$982.8K
GoHealth, Inc.
Shares:25.1K
Value:$694.4K
Marker Therapeutics, Inc.
Shares:554.3K
Value:$681.7K
020952107
Shares:394.1K
Value:$454.2K
Roivant Sciences Ltd.
Shares:39.0K
Value:$393.5K
824430300
Shares:75.9K
Value:$325.6K